Key Financial Data Of Reporting Company

Immuno-Biological Laboratories Co., Ltd. - Filing #7732463

Concept 2017-07-01 to
2017-09-30
2017-04-01 to
2017-09-30
As at
2017-09-30
2016-04-01 to
2017-03-31
As at
2017-03-31
2016-07-01 to
2016-09-30
2016-04-01 to
2016-09-30
As at
2016-09-30
Key financial data of reporting company
Business results of reporting company
Net sales
333,360,000 JPY
741,525,000 JPY
350,181,000 JPY
Ordinary profit (loss)
-37,636,000 JPY
-1,170,355,000 JPY
-108,466,000 JPY
Net assets
1,300,817,000 JPY
1,341,441,000 JPY
3,223,413,000 JPY
Total assets
3,311,170,000 JPY
3,425,900,000 JPY
4,056,440,000 JPY
Basic earnings (loss) per share
2.79
-5.47
-287.52
-6.73
-15.37
Diluted earnings per share
Equity-to-asset ratio
0.392 xbrli:pure
0.390 xbrli:pure
0.794 xbrli:pure
Net cash provided by (used in) operating activities
54,441,000 JPY
-55,886,000 JPY
-86,606,000 JPY
Net cash provided by (used in) investing activities
-9,900,000 JPY
-458,490,000 JPY
-511,951,000 JPY
Net cash provided by (used in) financing activities
-73,358,000 JPY
2,145,528,000 JPY
810,798,000 JPY
Cash and cash equivalents
2,493,918,000 JPY
2,522,102,000 JPY
1,101,450,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.